Pharmacy

Dec 25 2017

Patheon and DSM complete $ merger to form private company DPx #pharmaceutical #industry #marketing

#dsm pharma # Patheon and DSM complete $2.65bn merger to form private company ‘DPx’ By Dan Stanton+ Dan Stanton 12-Mar-2014 2014-03-12T00:00:00Z Last updated on 12-Mar-2014 at 09:49 GMT 2014-03-12T09:49:12Z Patheon has merged with Royal DSM’s pharmaceutical products business to form DPx in a $2.65bn (€1.9bn) deal that analysts believe has created the world’s second biggest CMO. Plans for the merger were announced in November last year, but the deal only completed yesterday. Under the new structure Patheon’s owner JLL Holdings has a 51% share in DPx with Royal DSM who controlling the remaining 49%. The new company will consist of …

Dec 18 2017

Patheon and DSM complete $ merger to form private company DPx #pharma #test

#dsm pharma # Patheon and DSM complete $2.65bn merger to form private company ‘DPx’ By Dan Stanton+ Dan Stanton 12-Mar-2014 2014-03-12T00:00:00Z Last updated on 12-Mar-2014 at 09:49 GMT 2014-03-12T09:49:12Z Patheon has merged with Royal DSM’s pharmaceutical products business to form DPx in a $2.65bn (€1.9bn) deal that analysts believe has created the world’s second biggest CMO. Plans for the merger were announced in November last year, but the deal only completed yesterday. Under the new structure Patheon’s owner JLL Holdings has a 51% share in DPx with Royal DSM who controlling the remaining 49%. The new company will consist of …

Nov 30 2017

Patheon and DSM complete $ merger to form private company DPx #novartis #pharma

#dsm pharma # Patheon and DSM complete $2.65bn merger to form private company ‘DPx’ By Dan Stanton+ Dan Stanton 12-Mar-2014 2014-03-12T00:00:00Z Last updated on 12-Mar-2014 at 09:49 GMT 2014-03-12T09:49:12Z Patheon has merged with Royal DSM’s pharmaceutical products business to form DPx in a $2.65bn (€1.9bn) deal that analysts believe has created the world’s second biggest CMO. Plans for the merger were announced in November last year, but the deal only completed yesterday. Under the new structure Patheon’s owner JLL Holdings has a 51% share in DPx with Royal DSM who controlling the remaining 49%. The new company will consist of …

Nov 14 2017

Patheon and DSM complete $ merger to form private company DPx #orbus #pharma

#dsm pharma # Patheon and DSM complete $2.65bn merger to form private company ‘DPx’ By Dan Stanton+ Dan Stanton 12-Mar-2014 2014-03-12T00:00:00Z Last updated on 12-Mar-2014 at 09:49 GMT 2014-03-12T09:49:12Z Patheon has merged with Royal DSM’s pharmaceutical products business to form DPx in a $2.65bn (€1.9bn) deal that analysts believe has created the world’s second biggest CMO. Plans for the merger were announced in November last year, but the deal only completed yesterday. Under the new structure Patheon’s owner JLL Holdings has a 51% share in DPx with Royal DSM who controlling the remaining 49%. The new company will consist of …

Aug 25 2017

Patheon and DSM complete $ merger to form private company DPx #dainippon #sumitomo #pharma

#dsm pharma # Patheon and DSM complete $2.65bn merger to form private company ‘DPx’ By Dan Stanton+ Dan Stanton 12-Mar-2014 2014-03-12T00:00:00Z Last updated on 12-Mar-2014 at 09:49 GMT 2014-03-12T09:49:12Z Patheon has merged with Royal DSM’s pharmaceutical products business to form DPx in a $2.65bn (€1.9bn) deal that analysts believe has created the world’s second biggest CMO. Plans for the merger were announced in November last year, but the deal only completed yesterday. Under the new structure Patheon’s owner JLL Holdings has a 51% share in DPx with Royal DSM who controlling the remaining 49%. The new company will consist of …

Mar 31 2017

Patheon and DSM complete $ merger to form private company DPx #pharma #magazine

#dsm pharma # Patheon and DSM complete $2.65bn merger to form private company ‘DPx’ By Dan Stanton+ Dan Stanton 12-Mar-2014 2014-03-12T00:00:00Z Last updated on 12-Mar-2014 at 09:49 GMT 2014-03-12T09:49:12Z Patheon has merged with Royal DSM’s pharmaceutical products business to form DPx in a $2.65bn (€1.9bn) deal that analysts believe has created the world’s second biggest CMO. Plans for the merger were announced in November last year, but the deal only completed yesterday. Under the new structure Patheon’s owner JLL Holdings has a 51% share in DPx with Royal DSM who controlling the remaining 49%. The new company will consist of …

Jan 30 2017

Patheon and DSM complete $ merger to form private company DPx #abbott #pharma

#dsm pharma # Patheon and DSM complete $2.65bn merger to form private company ‘DPx’ By Dan Stanton+ Dan Stanton 12-Mar-2014 2014-03-12T00:00:00Z Last updated on 12-Mar-2014 at 09:49 GMT 2014-03-12T09:49:12Z Patheon has merged with Royal DSM’s pharmaceutical products business to form DPx in a $2.65bn (€1.9bn) deal that analysts believe has created the world’s second biggest CMO. Plans for the merger were announced in November last year, but the deal only completed yesterday. Under the new structure Patheon’s owner JLL Holdings has a 51% share in DPx with Royal DSM who controlling the remaining 49%. The new company will consist of …

Dec 9 2016

Patheon and DSM complete $ merger to form private company DPx #gmp #pharma

#dsm pharma # Patheon and DSM complete $2.65bn merger to form private company ‘DPx’ By Dan Stanton+ Dan Stanton 12-Mar-2014 2014-03-12T00:00:00Z Last updated on 12-Mar-2014 at 09:49 GMT 2014-03-12T09:49:12Z Patheon has merged with Royal DSM’s pharmaceutical products business to form DPx in a $2.65bn (€1.9bn) deal that analysts believe has created the world’s second biggest CMO. Plans for the merger were announced in November last year, but the deal only completed yesterday. Under the new structure Patheon’s owner JLL Holdings has a 51% share in DPx with Royal DSM who controlling the remaining 49%. The new company will consist of …

Nov 21 2016

Patheon and DSM complete $ merger to form private company DPx #cipla

#dsm pharma # Patheon and DSM complete $2.65bn merger to form private company ‘DPx’ By Dan Stanton+ Dan Stanton 12-Mar-2014 2014-03-12T00:00:00Z Last updated on 12-Mar-2014 at 09:49 GMT 2014-03-12T09:49:12Z Patheon has merged with Royal DSM’s pharmaceutical products business to form DPx in a $2.65bn (€1.9bn) deal that analysts believe has created the world’s second biggest CMO. Plans for the merger were announced in November last year, but the deal only completed yesterday. Under the new structure Patheon’s owner JLL Holdings has a 51% share in DPx with Royal DSM who controlling the remaining 49%. The new company will consist of …

Nov 3 2016

Patheon and DSM complete $ merger to form private company DPx #pharma #agency

#dsm pharma # Patheon and DSM complete $2.65bn merger to form private company ‘DPx’ By Dan Stanton+ Dan Stanton 12-Mar-2014 2014-03-12T00:00:00Z Last updated on 12-Mar-2014 at 09:49 GMT 2014-03-12T09:49:12Z Patheon has merged with Royal DSM’s pharmaceutical products business to form DPx in a $2.65bn (€1.9bn) deal that analysts believe has created the world’s second biggest CMO. Plans for the merger were announced in November last year, but the deal only completed yesterday. Under the new structure Patheon’s owner JLL Holdings has a 51% share in DPx with Royal DSM who controlling the remaining 49%. The new company will consist of …

Sep 26 2016

Patheon and DSM complete $ merger to form private company DPx

#dsm pharma # Patheon and DSM complete $2.65bn merger to form private company ‘DPx’ By Dan Stanton+ Dan Stanton 12-Mar-2014 2014-03-12T00:00:00Z Last updated on 12-Mar-2014 at 09:49 GMT 2014-03-12T09:49:12Z Patheon has merged with Royal DSM’s pharmaceutical products business to form DPx in a $2.65bn (€1.9bn) deal that analysts believe has created the world’s second biggest CMO. Plans for the merger were announced in November last year, but the deal only completed yesterday. Under the new structure Patheon’s owner JLL Holdings has a 51% share in DPx with Royal DSM who controlling the remaining 49%. The new company will consist of …

Sep 17 2016

Patheon and DSM complete $ merger to form private company DPx

#dsm pharma # Patheon and DSM complete $2.65bn merger to form private company ‘DPx’ By Dan Stanton+ Dan Stanton 12-Mar-2014 2014-03-12T00:00:00Z Last updated on 12-Mar-2014 at 09:49 GMT 2014-03-12T09:49:12Z Patheon has merged with Royal DSM’s pharmaceutical products business to form DPx in a $2.65bn (€1.9bn) deal that analysts believe has created the world’s second biggest CMO. Plans for the merger were announced in November last year, but the deal only completed yesterday. Under the new structure Patheon’s owner JLL Holdings has a 51% share in DPx with Royal DSM who controlling the remaining 49%. The new company will consist of …